Microbiota-targeted Therapeutics
Cross-source consensus on Microbiota-targeted Therapeutics from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Evidence quality
Highlighted claims
- Dietary interventions, standalone prebiotics, and probiotics in functional foods are excluded from the review. — Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials
- Eligible microbiota-targeted interventions include probiotics, synbiotics, postbiotics, FMT, live biotherapeutic products, and antibiotics. — Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials
- The review evaluates microbiota-targeted interventions across autoimmune and inflammatory rheumatic diseases because no comprehensive, current review spans all such interventions and diseases. — Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials
- Microbiota-targeted therapies may act through changes in microbial composition and metabolites, gut barrier restoration, and pharmacomicrobiomic effects. — Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials